ENTITY
Innovent Biologics

Innovent Biologics (1801 HK)

617
Analysis
Health Care • China
Innovent Biologics is a biopharmaceutical company that discovers, develops, manufactures, and commercializes innovative medicines. The company focuses on therapeutic areas including oncology, autoimmune, cardiovascular and metabolic, and ophthalmology diseases, with 18 products currently on the market. Innovent Biologics was founded in 2011 and is headquartered in Suzhou, Jiangsu, China.
more
Exchange Announcement • 29 Sep 2026 16:36

2026 Interim Report

Exchange Announcement • 28 Sep 2026 18:09

Voluntary Announcement - Jaypirca (Pirtobrutinib) Approved In China For A New Indication In Chronic Lymphocytic Leukemia (Cll) /Small Lymphocytic Lymphoma (Sll) Across All Lines Of Therapy

Exchange Announcement • 01 Sep 2026 22:48

Grant Of Share Options And Restricted Shares

Exchange Announcement • 01 Sep 2026 20:16

List Of Directors And Their Role And Function

Exchange Announcement • 27 Aug 2026 22:50

Next Day Disclosure Return

x